Femring costs between $883 and $1,146 for a single ring, depending on the dose and where you fill your prescription. That’s roughly $300 to $380 per month for a medication you replace every three months. Several factors drive this price: Femring occupies a unique niche with no direct competitors, uses specialized drug delivery technology, and faces limited insurance coverage.
What Femring Actually Costs
The 0.05 mg Femring ring has an average retail price of about $1,074, while the higher 0.1 mg dose runs around $1,146. Discount programs like GoodRx can bring those numbers down to roughly $883 and $952 respectively, but that’s still a significant out-of-pocket expense for a single unit that lasts 90 days.
To put that in perspective, oral estrogen tablets and estrogen patches that treat the same symptoms typically cost a fraction of that amount, especially when generics are available. The price gap between Femring and other forms of hormone therapy is one of the main reasons people search for answers about its cost.
No Direct Competitors on the Market
The single biggest reason Femring commands such a high price is that it has no real competition. It is the only vaginal ring approved to deliver systemic levels of estrogen, meaning it’s designed to get estrogen into your bloodstream at levels high enough to treat hot flashes, night sweats, and other menopause symptoms throughout your body. The 0.05 mg and 0.1 mg rings achieve average blood estrogen concentrations of 41 to 76 pg/mL, which is enough to meaningfully reduce the frequency and severity of vasomotor symptoms.
People sometimes confuse Femring with Estring, a lower-dose vaginal ring that releases only about 7.5 micrograms of estrogen per day. Estring is designed for a completely different purpose: treating vaginal dryness and irritation locally, without raising estrogen levels throughout the body. Because Estring keeps blood estrogen levels low (generally below 19 pg/mL), it doesn’t require the addition of a progestogen to protect the uterine lining. Femring does, because it functions as full systemic hormone therapy delivered through the vagina.
When a drug is the only product in its category, there’s no market pressure to lower the price. No generic version of Femring is widely available, and no other manufacturer sells a systemic estrogen vaginal ring. That monopoly position gives the manufacturer significant pricing power.
Specialized Manufacturing Adds Cost
Vaginal rings are not simple pills pressed from powder. They’re engineered devices that must release a precise, consistent amount of medication over 90 days. The ring contains an estradiol acetate reservoir surrounded by a polymer shell, and drug release depends on a three-step process: the drug dissolves into the surrounding polymer, diffuses through it, and then partitions from the ring’s surface into vaginal fluid. This passive diffusion has to remain stable for three full months.
Manufacturing these rings requires medical-grade silicone elastomers or thermoplastic polymers like polyethylene vinyl acetate and polyurethane, produced through injection molding or hot-melt extrusion. Medical-grade materials are more expensive than standard pharmaceutical ingredients, and the availability of qualified materials is limited. The manufacturing process also demands tight quality controls to ensure each ring delivers the right dose consistently over its entire lifespan. All of this adds to production costs compared to a standard oral tablet or transdermal patch.
Insurance Coverage Is Often Limited
Even with insurance, Femring can be difficult to get covered at a reasonable copay. Many insurance formularies place it in a high cost-sharing tier or classify it as non-formulary entirely. The VA health system, for example, lists Femring as non-formulary at Tier 3, meaning veterans need prior authorization and a special non-formulary drug request before it can be dispensed. Private insurance plans often follow similar patterns, requiring prior authorization or step therapy (trying cheaper alternatives first) before approving coverage.
The logic from the insurer’s perspective is straightforward: oral estrogen pills and estrogen patches can deliver systemic hormone therapy at a much lower cost. Insurers want patients to try those options first. If you have a clinical reason why oral or transdermal estrogen doesn’t work for you, your doctor can submit a prior authorization request, but the process adds time and paperwork with no guarantee of approval.
Why Some People Choose Femring Anyway
Given the price, it’s worth understanding why Femring exists as a product at all. Some women prefer it because the ring only needs to be replaced every three months, which means less daily or weekly attention to their hormone therapy. There’s no pill to remember every morning, no patch to change every few days, and no cream to apply. For women who travel frequently, have difficulty with adherence, or simply prefer a low-maintenance approach, that convenience holds real value.
The vaginal route also bypasses the digestive system and liver on the first pass, which can reduce certain metabolic side effects associated with oral estrogen. For women who experience gastrointestinal issues with pills or skin irritation from patches, Femring offers an alternative delivery method while still achieving systemic estrogen levels effective against hot flashes and other vasomotor symptoms.
Ways to Reduce the Cost
Discount programs like GoodRx can save $100 to $200 per ring compared to full retail price. It’s also worth checking whether the manufacturer offers a patient assistance program or copay card, as brand-name drugs in niche categories sometimes do.
If the cost is simply prohibitive, the most practical conversation to have with your prescriber is whether a different form of systemic estrogen therapy could work for you. Estrogen patches, for instance, also avoid first-pass liver metabolism and are available as generics at a fraction of Femring’s price. Oral estrogen is even cheaper. The tradeoff is the convenience of a set-it-and-forget-it ring versus a daily pill or weekly patch, but for many women, that tradeoff saves hundreds of dollars every three months.